Correlation Between Milestone Pharmaceuticals and NeuroSense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Milestone Pharmaceuticals and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Milestone Pharmaceuticals and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Milestone Pharmaceuticals and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Milestone Pharmaceuticals and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Milestone Pharmaceuticals with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Milestone Pharmaceuticals and NeuroSense Therapeutics.
Diversification Opportunities for Milestone Pharmaceuticals and NeuroSense Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Milestone and NeuroSense is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Milestone Pharmaceuticals and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Milestone Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Milestone Pharmaceuticals are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Milestone Pharmaceuticals i.e., Milestone Pharmaceuticals and NeuroSense Therapeutics go up and down completely randomly.
Pair Corralation between Milestone Pharmaceuticals and NeuroSense Therapeutics
Given the investment horizon of 90 days Milestone Pharmaceuticals is expected to generate 5.39 times less return on investment than NeuroSense Therapeutics. But when comparing it to its historical volatility, Milestone Pharmaceuticals is 8.57 times less risky than NeuroSense Therapeutics. It trades about 0.36 of its potential returns per unit of risk. NeuroSense Therapeutics Ltd is currently generating about 0.23 of returns per unit of risk over similar time horizon. If you would invest 18.00 in NeuroSense Therapeutics Ltd on September 1, 2024 and sell it today you would earn a total of 6.00 from holding NeuroSense Therapeutics Ltd or generate 33.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 71.43% |
| Values | Daily Returns |
Milestone Pharmaceuticals vs. NeuroSense Therapeutics Ltd
Performance |
| Timeline |
| Milestone Pharmaceuticals |
| NeuroSense Therapeutics |
Milestone Pharmaceuticals and NeuroSense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Milestone Pharmaceuticals and NeuroSense Therapeutics
The main advantage of trading using opposite Milestone Pharmaceuticals and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Milestone Pharmaceuticals position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.The idea behind Milestone Pharmaceuticals and NeuroSense Therapeutics Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| NeuroSense Therapeutics vs. Neurosense Therapeutics | NeuroSense Therapeutics vs. Pasithea Therapeutics Corp | NeuroSense Therapeutics vs. GeoVax Labs | NeuroSense Therapeutics vs. NLS Pharmaceutics AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |